Cut jobs not likely to reappear

Pharma's shift into emerging markets and away from established sales and marketing routines leads to permanent job cuts, says The Economist. That's in contrast to job cuts that normally accompany a recession, which are reversible when the economy improves.  Jobs that are disappearing now will probably not reappear, but that may help save other jobs by shoring up pharma company profits. Article

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.